论文信息 - PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial - 字舞流文

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

D. Gaudet | F. Raal | F. Civeira | B. Cariou | I. Gouni-Berthold | S. Wasserman | R. Scott | R. Dufour | G. Hovingh | G. Langslet | L. Burgess | T. Turner | R. Somaratne | D. Sullivan | Evan A Stein | Russell Scott | Anders G Olsson | Ian Bridges | I. Bridges | Russell Scott